TUDOR INVESTMENT CORP ET AL - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 96 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$16,730,000
+2454.2%
700,015
+1418.1%
0.34%
+1100.0%
Q3 2020$655,000
+186.0%
46,110
+196.7%
0.03%
+154.5%
Q2 2020$229,000
-55.8%
15,541
-85.6%
0.01%
-52.2%
Q4 2019$518,000
-30.5%
107,750
-12.4%
0.02%
-11.5%
Q3 2019$745,000
+138.8%
122,981
+155.7%
0.03%
+188.9%
Q2 2019$312,000
-57.9%
48,099
-23.2%
0.01%
-60.9%
Q2 2017$741,00062,6520.02%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,365,000$16,186,0001.49%
CADIAN CAPITAL MANAGEMENT, LP 5,517,767$26,540,0001.17%
NEEDHAM INVESTMENT MANAGEMENT LLC 1,590,000$7,646,0001.04%
Parkman Healthcare Partners LLC 420,000$2,020,0000.58%
Penn Capital Management Company, LLC 977,526$4,702,0000.49%
Bullseye Asset Management LLC 79,272$381,0000.37%
Bellevue Group AG 2,441,241$11,742,0000.19%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,783$1,447,0000.18%
Granite Investment Partners, LLC 589,313$2,835,0000.13%
WRAPMANAGER INC 68,163$328,0000.10%
View complete list of GENMARK DIAGNOSTICS INC shareholders